Rosalind Advisors, Inc. 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-01-22 5:26 pm Purchase |
2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Rosalind Advisors, Inc. | 179,237 4.800% |
45,904![]() (+34.43%) |
Filing |
2020-09-18 4:56 pm Purchase |
2020-09-15 | 13G | VistaGen Therapeutics, Inc. VTGN |
Rosalind Advisors, Inc. | 133,333 5.400% |
133,333![]() (New Position) |
Filing |